Seres Therapeutics
Speed Read
0%
300 WPM
-- remaining
Microbiome therapeutics company developing biological drugs designed to treat diseases by modulating the microbiome. Focuses on gastrointestinal diseases and oncology applications. Pioneering approach using rationally designed bacterial consortia.